To test the potential impact of DNA methylation at the CpG sites identified in a relevant tissue for stroke pathogenesis, the CRISPR/dCas9-Dnmt3a system was used to experimentally induce increased DNA methylation levels in the gene regions of interest in human umbilical endothelial cells (HUVECs). The gene discussed is DNMT3A; the disease is stroke disorder.